Differences

This shows you the differences between two versions of the page.

Link to this comparison view

public:publications [2015/02/12 16:50]
f.demichelis@unitn.it
public:publications [2016/10/18 14:27] (current)
f.demichelis@unitn.it
Line 1: Line 1:
-===== Selected Publications (2010-2015) =====+==== Selected Publications (2010-2016) ==== 
 + 
 +=== 2016 === 
 + 
 +Bishoy M. Faltas*, Davide Prandi*, Scott T. Tagawa, Ana M. Molina, David M. Nanus, Cora Sternberg, Jonathan Rosenberg, Juan Miguel Mosquera, Brian Robinson, Olivier Elemento, Andrea Sboner, Himisha Beltran*, Francesca Demichelis*, Mark A. Rubin*. **Clonal Evolution of Chemotherapy-resistant Urothelial Carcinoma.** Nat Genet. 2016 Oct 17. doi: 10.1038/ng.3692. 
 + 
 +Etienne Dardenne*, Himisha Beltran*, Matteo Benelli, Kaitlyn Gayvert, Adeline Berger, Loredana Puca, Joanna Cyrta, Andrea Sboner, Zohal Noorzad, Theresa MacDonald, Cynthia Cheung, Ka Shing Yuen, Dong Gao, Yu Chen, Martin Eilers, Juan-Miguel Mosquera, Brian D. Robinson, Olivier Elemento, Mark A. Rubin, Francesca Demichelis and David S. Rickman. **N-Myc induces an EZH2-mediated transcriptional program driving Neuroendocrine Prostate Cancer.** Cancer Cell. 2016 Oct 10;30(4):563-577. 
 + 
 + 
 +Beltran H*, Prandi D*, Mosquera JM, Benelli M, Puca L, Cyrta J, Marotz C, Giannopoulou E, Chakravarthi BV, Varambally S, Tomlins SA, Nanus DM, Tagawa ST, Van Allen EM, Elemento O, Sboner A, Garraway LA*, Rubin MA*, Demichelis F*. **Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.** Nat Med. 2016 Mar;22(3):298-305. 
 + 
 + 
 +Khurana E, Fu Y, Chakravarty D, Demichelis F, Rubin MA, Gerstein M. **Role of non-coding sequence variants in cancer.** Nat Rev Genet. 2016 Feb;17(2):93-108. doi: 10.1038/nrg.2015.17. Epub 2016 Jan 19. 
 + 
 + 
 +Rubin MA, Girelli G, Demichelis F. **Genomic Correlates to the newly proposed Grading Prognostic Groups for Prostate Cancer.** Eur Urol. 2016 Apr;69(4):557-60.
  
 === 2015 === === 2015 ===
  
-Romanel A, Lago S, Prandi D, Sboner A, Demichelis F. **ASEQ: fast allele-specific studies from next-generation sequencing data.** BMC Medical Genomics (in press)+The Cancer Genome Atlas Research Network (including Davide Prandi and Francesca Demichelis). **The Molecular Taxonomy of Primary Prostate Cancer**. Cell 4(163), 1011-1025, 2015. 
 + 
 +Romanel A*, Gasi Tandefelt D*, Conteduca C, Jayaram A, Casiraghi N, Wetterskog DSalvi S, Amadori D, Zafeiriou Z, Rescigno P, Bianchini D, Gurioli G, Casadio V, Carreira S, Goodall J, Wingate A, Ferraldeschi R, Tunariu N, Flohr P, De Giorgi U, de Bono JS, Demichelis F*, Attard G*. **Plasma AR and abiraterone-resistant prostate cancer**Science Translational Medicine 7, 312re10, 2015. 
 + 
 +Boysen G*, Barbieri CE*, Prandi D, Blattner M, Chae SS, Dahija A, Nataraj S, Huang D, Marotz C, Xu L, Huang J, Lecca P, Chhangawala S, Liu D, Zhou P, Sboner A, de Bono JS, Demichelis F*, Houvras Y*, Rubin MA*. **SPOP mutation leads to genomic instability in prostate cancer.** Elife. 2015 Sep 16;4. doi: 10.7554/eLife.09207.
  
-Garritano S*, Romanel A*, Ciribilli Y*, Bisio A, Gavoci A, Inga A#, Demichelis F#. **In-silico identification and functional validation of allele-dependent AR enhancers.** Oncotarget (in press)+Beltran H, Demichelis F. **Prostate cancer: Intrapatient heterogeneity in prostate cancer.** Nat Rev Urol. 2015 Aug;12(8):430-1. Nature Reviews Urology | News and Views
  
 +Robinson D, Van Allen EM, et al. **Integrative clinical genomics of advanced prostate cancer.** Cell. 2015 May 21;161(5):1215-28. doi: 10.1016/j.cell.2015.05.001. SU2C-PCF 
  
 +Beltran H, Eng K, Mosquera JM, Sigaras A, Romanel A, Rennert H, Kossai M, Pauli C, Faltas B, Fontugne J, Park K, Banfelder J, Prandi D, Madhukar N, Zhang T, Padilla J, Greco N, McNary T, Herrscher E, Wilkes D, MacDonald T, Xue H, Vacic V, Emde AK, Oschwald D , Tan A, Chen Z, Collins C, Gleave M, Wang Y, Chakravarty D, Schiffman M, Kim R, Campagne F, Robinson B, Nanus D, Tagawa S, Xiang J, Smogorzewska A, Demichelis F, Rickman D, Sboner A, Elemento O, Rubin MA. **Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.** Jama Oncology, 2015.
  
 +Romanel A, Lago S, Prandi D, Sboner A, Demichelis F. **ASEQ: fast allele-specific studies from next-generation sequencing data.** BMC Medical Genomics  8(1):9, 2015.
  
 +Garritano S*, Romanel A*, Ciribilli Y*, Bisio A, Gavoci A, Inga A*, Demichelis F*. **In-silico identification and functional validation of allele-dependent AR enhancers.** Oncotarget 6(7):4816-4828, 2015.
  
  
-===== 2014 =====+=== 2014 ===
  
 Carreira S*, Romanel A*, Goodall J*, Grist E, Ferraldeschi R, Miranda S, Prandi D, Lorente D, Frenel J-S, Pezaro C, Omlin A, Rodrigues DN, Flohr P, Tunariu N, de Bono JS, Demichelis F*, Attard G*. **Tumor clone dynamics in lethal prostate cancer.** Science Translational Medicine 2014, 6:254ra125. Carreira S*, Romanel A*, Goodall J*, Grist E, Ferraldeschi R, Miranda S, Prandi D, Lorente D, Frenel J-S, Pezaro C, Omlin A, Rodrigues DN, Flohr P, Tunariu N, de Bono JS, Demichelis F*, Attard G*. **Tumor clone dynamics in lethal prostate cancer.** Science Translational Medicine 2014, 6:254ra125.
Line 24: Line 47:
  
  
-===== 2013 =====+=== 2013 ===
  
 Park K, Chiu YL, Rubin MA, Demichelis F(*), Mosquera JM(*). **V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.** Hum Pathol. 2013 Jul 12. doi:pii: S0046-8177(13)00199-8. 10.1016/j.humpath.2013.05.010. [Epub ahead of print] Park K, Chiu YL, Rubin MA, Demichelis F(*), Mosquera JM(*). **V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.** Hum Pathol. 2013 Jul 12. doi:pii: S0046-8177(13)00199-8. 10.1016/j.humpath.2013.05.010. [Epub ahead of print]
Line 43: Line 66:
  
  
-===== 2012 =====+=== 2012 ===
  
 Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JYH, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan M, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA.** Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk**. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6686-91. Demichelis F, Setlur SR, Banerjee S, Chakravarty D, Chen JYH, Chen CX, Huang J, Beltran H, Oldridge DA, Kitabayashi N, Stenzel B, Schaefer G, Horninger W, Bektic J, Chinnaiyan AM, Goldenberg S, Siddiqui J, Regan M, Kearney M, Soong TD, Rickman DS, Elemento O, Wei JT, Scherr DS, Sanda MA, Bartsch G, Lee C, Klocker H, Rubin MA.** Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk**. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6686-91.
Line 51: Line 74:
 Barbieri CE, Baca SC, Lawrence MS, Demichelis F, et al. **Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer**. Nat Genet. 2012 May 20;44(6):685-9. Barbieri CE, Baca SC, Lawrence MS, Demichelis F, et al. **Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer**. Nat Genet. 2012 May 20;44(6):685-9.
  
-===== 2011 =====+=== 2011 ===
  
 Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA. **Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets**. Cancer Discovery. 2011 Nov;1(6): 487-495. Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA. **Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets**. Cancer Discovery. 2011 Nov;1(6): 487-495.
Line 61: Line 84:
 Banerjee S, Oldridge D, Poptsova M, Hussain WM, Chakravarty D, Demichelis F. **A computational framework discovers new copy number variants with functional importance**. PLoS One. 2011 Mar 29;6(3):e17539. Banerjee S, Oldridge D, Poptsova M, Hussain WM, Chakravarty D, Demichelis F. **A computational framework discovers new copy number variants with functional importance**. PLoS One. 2011 Mar 29;6(3):e17539.
  
-===== 2010 =====+=== 2010 ===
  
 Setlur SR, Chen CX, Hossain RR, Ha JS, Van Doren VE, Stenzel B, Steiner E, Oldridge D, Katabayashi N, Banerjee S, Chen JY, Schäfer G, Horninger W, Lee C, Rubin MA, Klocker H, and Demichelis F. **Genetic Variation of Genes involved in Dihydrotestosterone Metabolism and the risk of prostate cancer**. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):229-39. Setlur SR, Chen CX, Hossain RR, Ha JS, Van Doren VE, Stenzel B, Steiner E, Oldridge D, Katabayashi N, Banerjee S, Chen JY, Schäfer G, Horninger W, Lee C, Rubin MA, Klocker H, and Demichelis F. **Genetic Variation of Genes involved in Dihydrotestosterone Metabolism and the risk of prostate cancer**. Cancer Epidemiol Biomarkers Prev. 2010 Jan;19(1):229-39.